Langabeer, S. (2018) “The JAK2 V617F mutation in lung cancer: caveat emptor”, Experimental Oncology, 40(4), pp. 343–344. Available at: https://exp-oncology.com.ua/index.php/Exp/article/view/2018-4-1 (Accessed: 4 May 2026).